Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionTruist Financial Corp
Latest Disclosed Ownership941,818 shares
Latest Disclosed Value $ 143,862,697
Truist Financial Corp ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 27, 2026 - Truist Financial Corp filed a 13F-HR form disclosing ownership of 941,818 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $143,862,700 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 887,296 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 6.14% during the quarter. The current value of the position is $135,301,574 USD.

Truist Financial Corp has a history of taking positions in derivatives of the underlying security (NVS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NVS / Novartis AG - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 941,818 54,522 6.14 143,863 17.60 0.1939
2026-02-02 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 887,296 54,682 6.57 122,332 14.57 0.1631
2025-11-03 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 832,614 34,147 4.28 106,774 10.51 0.1444
2025-07-18 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 798,467 28,726 3.73 96,622 12.60 0.1414
2025-04-29 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 769,741 -1,914 -0.25 85,811 14.28 0.1373
2025-01-31 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 771,655 27,092 3.64 75,090 -12.32 0.1175
2024-11-13 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 744,563 -5,842 -0.78 85,640 7.20 0.1342
2024-08-21 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 750,405 -5,657 -0.75 79,888 9.24 0.1215
2024-05-13 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 756,062 -74,303 -8.95 73,134 -12.77 0.1108
2024-02-02 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 830,365 -33,494 -3.88 83,842 -4.72 0.1333
2023-11-14 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 863,859 85,075 10.92 87,993 11.97 0.1470
2023-08-01 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 778,784 -52,632 -6.33 78,587 2.74 0.1306
2023-05-05 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 831,416 -124,363 -13.01 76,490 -11.78 0.1316
2023-02-17 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 955,779 -10,416 -1.08 86,708 18.07 0.1525
2022-10-26 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 966,195 -8,089 -0.83 73,440 -10.83 0.1409
2022-07-22 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 974,284 -120,349 -10.99 82,356 -14.26 0.1512
2022-04-22 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,094,633 76,233 7.49 96,054 7.83 0.1516
2022-02-14 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 1,018,400 -16,861 -1.63 89,080 5.22 0.1357
2021-11-05 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 1,035,261 35,423 3.54 84,664 -7.19 0.1389
2021-08-16 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 999,838 31,103 3.21 91,225 10.17 0.1492
2021-05-17 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 968,735 76,499 8.57 82,807 -1.72 0.1440
2021-11-19 2020-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 892,236 54,765 6.54 84,254 15.69 0.1611
2021-02-18 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 892,236 54,765 84,254 0.1565
2021-11-05 2020-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 837,471 6,719 0.81 72,826 0.37 0.1591
2020-11-13 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 835,654 6,599 72,668 0.1570
2021-11-16 2020-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 830,752 27,160 3.38 72,559 9.51 0.1631
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 829,055 25,463 72,411 0.1607
2021-11-05 2020-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 803,592 52,164 6.94 66,256 -6.88 0.1744
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 801,895 51,984 66,116 0.1725
2021-11-16 2019-12-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 751,428 604,435 411.20 71,153 457.01 0.1446
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 749,911 602,918 71,009 0.1431
2019-10-31 2019-09-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 146,993 -3,816 -2.53 12,774 -7.23 0.2192
2019-07-24 2019-06-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 150,809 -6,876 -4.36 13,770 -9.17 0.2385
2019-04-23 2019-03-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 157,685 -11,700 -6.91 15,160 4.31 0.2707
2019-01-22 2018-12-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 169,385 -5,584 -3.19 14,534 -3.59 0.2978
2018-10-17 2018-09-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 174,969 -2,296 -1.30 15,075 12.58 0.2709
2018-07-26 2018-06-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 177,265 -29,300 -14.18 13,391 -19.82 0.2548
2018-04-20 2018-03-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 206,565 -33,261 -13.87 16,701 -17.06 0.3186
2018-01-29 2017-12-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 239,826 -71,767 -23.03 20,136 -24.73 0.3763
2017-10-23 2017-09-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 311,593 -9,357 -2.92 26,751 -0.14 0.5192
2017-07-20 2017-06-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 320,950 -5,662 -1.73 26,789 10.43 0.5312
2017-04-28 2017-03-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 326,612 24,951 8.27 24,258 10.40 0.4876
2017-02-02 2016-12-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 301,661 8,357 2.85 21,972 -5.13 0.4489
2016-11-01 2016-09-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 293,304 2,755 0.95 23,160 -3.40 0.4760
2016-08-01 2016-06-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 290,549 9,623 3.43 23,974 17.81 0.5037
2016-05-05 2016-03-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 280,926 15,021 5.65 20,350 -11.05 0.5264
2016-01-28 2015-12-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 265,905 -12,466 -4.48 22,878 -10.59 0.5934
2015-11-04 2015-09-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 278,371 -10,454 -3.62 25,587 -9.92 0.6651
2015-07-29 2015-06-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 288,825 -15,612 -5.13 28,404 -5.38 0.7673
2015-04-23 2015-03-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 304,437 -36,411 -10.68 30,020 -4.95 0.8619
2015-01-26 2014-12-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 340,848 -4,981 -1.44 31,583 -2.98 0.9270
2014-10-21 2014-09-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 345,829 -12,168 -3.40 32,553 0.44 0.9839
2014-07-21 2014-06-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 357,997 -12,805 -3.45 32,409 2.80 0.9714
2014-04-28 2014-03-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 370,802 -2,873 -0.77 31,526 4.96 0.9933
2014-01-27 2013-12-31 13F NOVARTIS A G FOREIGN STOCK 66987V109 373,675 8,341 2.28 30,035 7.17 0.9676
2013-10-22 2013-09-30 13F NOVARTIS A G FOREIGN STOCK 66987V109 365,334 8,924 2.50 28,025 11.21 0.9929
2013-07-15 2013-06-30 13F NOVARTIS A G FOR 66987V109 356,410 356,410 25,201 0.9386
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-14 2021-03-31 13F NOVARTIS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-19 2020-12-31 13F/A NOVARTIS COM Call 2,500 0.00 236 8.76 n/a n/a n/a
2021-02-18 2020-12-31 13F NOVARTIS COM Call 2,500 236 n/a n/a n/a
2021-11-05 2020-09-30 13F/A NOVARTIS COM Call 2,500 0.00 217 -0.46 n/a n/a n/a
2020-11-13 2020-09-30 13F NOVARTIS COM Call 2,500 217 n/a n/a n/a
2021-11-16 2020-06-30 13F/A NOVARTIS COM Call 2,500 0.00 218 5.83 n/a n/a n/a
2020-08-14 2020-06-30 13F NOVARTIS COM Call 2,500 218 n/a n/a n/a
2021-11-05 2020-03-31 13F/A NOVARTIS A G COM Call 2,500 0.00 206 -13.08 n/a n/a n/a
2020-05-15 2020-03-31 13F NOVARTIS A G COM Call 2,500 206 n/a n/a n/a
2021-11-16 2019-12-31 13F/A NOVARTIS A G COM Call 2,500 237 n/a n/a n/a
2020-02-14 2019-12-31 13F NOVARTIS A G COM Call 2,500 237 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.